US Broker Ratings

Cytokinetics, Incorporated (CYTK) Stock Analysis: Significant 42% Upside Potential Beckons Investors

Cytokinetics, Incorporated (NASDAQ: CYTK), a pioneering biopharmaceutical company, has been making waves in the biotechnology sector with its innovative approach to addressing debilitating diseases through muscle activators and inhibitors. With..

Atrium Therapeutics, Inc. (RNA)

⚠️ No article content returned.

..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: 59.38% Potential Upside Ignites Investor Interest

iRhythm Holdings, Inc. (NASDAQ: IRTC) stands at the forefront of the digital healthcare sector, focusing on the design and commercialization of cutting-edge medical devices for cardiac monitoring. As the U.S...

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 9.10% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector specializing in medical instruments and supplies, has piqued investor interest with its innovative offerings such as Invisalign clear..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a Potential 16.52% Upside in Healthcare

Investors with an eye on the healthcare sector may want to take a closer look at The Ensign Group, Inc. (NASDAQ: ENSG), a company that has carved out a robust..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Evaluating a 12.81% Potential Upside in Medical Devices

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the healthcare sector, remains a key player in the medical devices industry. Founded in 1927 and headquartered in Warsaw, Indiana, the..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating the 33.89% Potential Upside

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, operates within the medical instruments and supplies industry. The company, with a market capitalization of $5.39 billion, is headquartered..

Genmab A/S (GMAB) Stock Analysis: Unlocking a 40% Upside Potential with Biotech Innovation

Genmab A/S (NASDAQ: GMAB), an influential player in the biotechnology sector, commands attention with its promising portfolio of antibody-based products aimed at combating cancer and other severe diseases. Headquartered in..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring an 8.41% Potential Upside in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, has carved a niche within the medical devices industry. With a market capitalization of $2.96 billion, ITGR stands..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a 15.59% Potential Upside in Genetic Medicine Innovations

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector, primarily focusing on developing genetic medicines that address diseases with unmet medical needs. As the company continues to..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Mixed Bag of Market Signals

Oscar Health, Inc. (NYSE: OSCR), with its innovative approach to healthcare technology, stands at an intriguing juncture for investors. As the company continues to carve a niche within the competitive..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a 56.82% Upside Potential in Healthcare Imaging

RadNet, Inc. (NASDAQ: RDNT) is carving out a significant niche within the healthcare sector, specifically in diagnostics and research. With its headquarters in Los Angeles, California, RadNet provides essential outpatient..

Insmed Incorporated (INSM) Stock Analysis: Unveiling a Potential 57% Upside with Cutting-Edge Biotech Innovations

Investors with a keen eye on the biotechnology sector may find Insmed Incorporated (NASDAQ: INSM) an intriguing proposition. Despite a recent dip in share price to $135.17, representing a minor..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating a 7.38% Potential Upside in the Healthcare Sector

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable force in the healthcare sector, boasting a market capitalization of $119.87 billion. Known for its innovative approach in biopharmaceuticals, the company..

Regencell Bioscience Holdings (RGC) Stock Analysis: High Valuation and Technical Indicators Signal Investor Interest

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a name that resonates within the healthcare sector, particularly in the niche of Traditional Chinese Medicine (TCM), is drawing attention from investors. With its..

Legend Biotech Corporation (LEGN): Investor Outlook Reveals a Promising 139% Upside Amidst Strong Buy Ratings

Legend Biotech Corporation (NASDAQ: LEGN) stands out in the biotechnology sector with its innovative focus on cell therapies, primarily targeting oncology. As a key player in the healthcare industry, the..

Natera, Inc. (NTRA) Stock Analysis: Unpacking a 26.63% Potential Upside in the Booming Diagnostics Sector

For investors keen on the healthcare sector, particularly the diagnostics and research industry, Natera, Inc. (NASDAQ: NTRA) presents an intriguing opportunity. With a market cap of $29.09 billion, this U.S.-based..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Evaluating a 28% Potential Upside Amidst Healthcare Innovation

Inspire Medical Systems, Inc. (NASDAQ: INSP), a trailblazer in the healthcare sector, is making waves with its revolutionary approach to treating obstructive sleep apnea (OSA). As investors seek high-growth opportunities..

Glaukos Corporation (GKOS) Stock Analysis: A Visionary in Medical Devices with 14.35% Potential Upside

Glaukos Corporation (NYSE: GKOS), a pioneering force in the healthcare sector, has captured the attention of investors with its innovative approach to treating eye disorders and impressive market performance. The..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Unlocking a Potential 11% Upside with Strong Buy Ratings

Lantheus Holdings, Inc. (NASDAQ: LNTH) is capturing investor attention with its promising growth trajectory in the healthcare sector. With a market capitalization of $5.49 billion, the company stands out as..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds